Turkish Validity and Reliability of The Tampa Scale for Kinesiophobia for Temporomandibular Disorders

November 24, 2020 updated by: Eylem KÜÇÜK, Okan University

Objective: The aim of this study is to evaluate the validity and reliability of the Turkish version of the 'The Tampa Scale for Kinesiophobia for Temporomandibular Disorders (TSK-TMD)' questionnaire used to assess kinesiophobia in temporomandibular joint disorders.

Method: The "Tampa Kinesiophobia Scale in Temporomandibular Disorders" (TSK-TMD), which consists of 12 item, was adapted to Turkish with the translation and back-translation method. 111 patients (75 females, 36 males) who had been diagnosed with temporomandibular joint for at least 6 months and diagnosed as Temporomandibular Joint Disorder were participated to fill out the questionnaire. In the present study, participants were assessed with the Temporomandibular joint disorders evaluation form, Turkish TSK-TMD-12 item, Visuel Analogue Scale (VAS) and Pain Catastrophizing Scale (PCS). The internal consistency and test-retest reliability with a 3-5 days time were used to evaluate the reliability of the TSK-TMD. The reliability of the corelatıon was checked with PCS. Construct validity was assessed based on confirmatory factor analysis (CFA).

Study Overview

Status

Completed

Detailed Description

We used Turkish TSK-TMD-12 item, Visuel Analogue Scale (VAS) and Pain Catastrophizing Scale (PCS) questionnaires in our study.

Study Type

Observational

Enrollment (Actual)

111

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Pre-test: 10 patients temporomandibular disorders evaluated. Inclusion and exlusion criteria listed above.

Validation and reliability: 111 patients with temporomandibular disorders evaluated.Inclusion and exlusion criteria listed above.

Description

Inclusion Criteria::

  • volunteer participation in the study, between 18 and 65 years old,
  • having symptoms for at least 6 months,
  • being literate, and having communication to understand and answer questions.

Exclusion Criteria:

  • toothache
  • Cognitive impairment affecting their ability to understand and complete the study questionnaire

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Only
  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
Validity and reliability

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Tampa Scale for Kinesiophobia for Temporomandibular Disorders
Time Frame: The measurement is one-time and take 20 minutes. It take an average of 6 month after the data of all participants are collected.
The original TSK-TMD is an English scale and consists of 18 items to evaluate the fear of movement in TMD patients. 4-point Likert type scoring is used (1-strongly disagree, 2-partially disagree, 3-partially agree and 4- strongly agree). Total score is calculated by reversing 4, 8, 12, 16 items. In this short form, by collecting all points, scores between 12-48 are obtained. The higher the person's score indicates, the higher the kinesiophobia. They suggested that the 12-item version had good reliability and validity as a result of the structural reliability assessment and was more suitable for evaluation in TMD patients.
The measurement is one-time and take 20 minutes. It take an average of 6 month after the data of all participants are collected.
Pain Catastrophizing Scala
Time Frame: The measurement is one-time and take 15 minutes. It take an average of 6 month after the data of all participants are collected.
It is a scale developed to detect catastrophic thoughts or feelings and ineffective coping methods of pain experienced by patients in the past. It describes the different thoughts and feelings that individuals can experience while suffering. PCS is a scale consisting of thirteen items and three factors such as helplessness, enlargement and self-reflection. Likert type scoring is evaluated between 0-4 points. The total score ranges from 0-52.
The measurement is one-time and take 15 minutes. It take an average of 6 month after the data of all participants are collected.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2016

Primary Completion (Actual)

August 2, 2017

Study Completion (Actual)

August 2, 2017

Study Registration Dates

First Submitted

November 18, 2020

First Submitted That Met QC Criteria

November 24, 2020

First Posted (Actual)

November 25, 2020

Study Record Updates

Last Update Posted (Actual)

November 25, 2020

Last Update Submitted That Met QC Criteria

November 24, 2020

Last Verified

November 1, 2020

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Temporomandibular Joint Disorders

3
Subscribe